VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 374 filers reported holding VANECK VECTORS ETF TR in Q2 2017. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,784,018 | -98.2% | 59,250 | -98.5% | 1.14% | -96.8% |
| Q3 2022 | $97,204,000 | +1320.1% | 4,030,000 | +1512.0% | 35.31% | +620.7% |
| Q2 2022 | $6,845,000 | -28.6% | 250,000 | 0.0% | 4.90% | -1.6% |
| Q1 2022 | $9,588,000 | +19.7% | 250,000 | 0.0% | 4.98% | +32.4% |
| Q4 2021 | $8,008,000 | -96.6% | 250,000 | -97.5% | 3.76% | -80.2% |
| Q3 2017 | $233,197,000 | +1712.5% | 10,156,700 | +1643.0% | 18.94% | +4062.4% |
| Q2 2017 | $12,866,000 | -94.8% | 582,700 | -95.1% | 0.46% | -96.8% |
| Q4 2016 | $246,827,000 | +87.0% | 11,798,600 | +136.3% | 14.07% | +241.4% |
| Q3 2016 | $131,962,000 | – | 4,992,900 | – | 4.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |